Selected research
Industry Research
Rapid-dissolving Tablets Industry Research Report 2026
Market perspective
The global Rapid-dissolving Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Rapid-dissolving Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Rapid-dissolving Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Rapid-dissolving Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Rapid-dissolving Tablets include Bristol-Myers Squibb, Conquer, Otsuka, AstraZeneca, GSK, Pfizer, Eli Lilly and Company, Mylan and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Rapid-dissolving Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Rapid-dissolving Tablets Market by Company
Bristol-Myers Squibb
Conquer
Otsuka
AstraZeneca
GSK
Pfizer
Eli Lilly and Company
Mylan
Merck
Johnson and Johnson
Teva
Rapid-dissolving Tablets Segment by Type
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Rapid-dissolving Tablets Segment by Application
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
Rapid-dissolving Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rapid-dissolving Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Rapid-dissolving Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rapid-dissolving Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Rapid-dissolving Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Rapid-dissolving Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Rapid-dissolving Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anti-Psychotics Drug
- Anti-Epileptics Drug
- Other
Applications
- CNS Diseases
- Gastrointestinal Diseases
- CVS Diseases
- Other
Companies covered
- Bristol-Myers Squibb
- Conquer
- Otsuka
- AstraZeneca
- GSK
- Pfizer
- Eli Lilly and Company
- Mylan
- Merck
- Johnson and Johnson
- Teva
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Rapid-dissolving Tablets Market Size (2021-2032)
- 2.2.2 Global Rapid-dissolving Tablets Sales (2021-2032)
- 2.2.3 Global Rapid-dissolving Tablets Market Average Price (2021-2032)
- 2.3 Rapid-dissolving Tablets by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Anti-Psychotics Drug
- 2.3.3 Anti-Epileptics Drug
- 2.3.4 Other
- 2.4 Rapid-dissolving Tablets by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 CNS Diseases
- 2.4.3 Gastrointestinal Diseases
- 2.4.4 CVS Diseases
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Rapid-dissolving Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Rapid-dissolving Tablets Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Rapid-dissolving Tablets Revenue of Manufacturers (2021-2026)
- 3.4 Global Rapid-dissolving Tablets Average Price by Manufacturers (2021-2026)
- 3.5 Global Rapid-dissolving Tablets Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Rapid-dissolving Tablets, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Rapid-dissolving Tablets, Product Type & Application
- 3.8 Global Manufacturers of Rapid-dissolving Tablets, Established Date
- 3.9 Global Rapid-dissolving Tablets Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bristol-Myers Squibb
- 4.1.1 Bristol-Myers Squibb Company Information
- 4.1.2 Bristol-Myers Squibb Business Overview
- 4.1.3 Bristol-Myers Squibb Rapid-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bristol-Myers Squibb Rapid-dissolving Tablets Product Portfolio
- 4.1.5 Bristol-Myers Squibb Recent Developments
- 4.2 Conquer
- 4.2.1 Conquer Company Information
- 4.2.2 Conquer Business Overview
- 4.2.3 Conquer Rapid-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Conquer Rapid-dissolving Tablets Product Portfolio
- 4.2.5 Conquer Recent Developments
- 4.3 Otsuka
- 4.3.1 Otsuka Company Information
- 4.3.2 Otsuka Business Overview
- 4.3.3 Otsuka Rapid-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Otsuka Rapid-dissolving Tablets Product Portfolio
- 4.3.5 Otsuka Recent Developments
- 4.4 AstraZeneca
- 4.4.1 AstraZeneca Company Information
- 4.4.2 AstraZeneca Business Overview
- 4.4.3 AstraZeneca Rapid-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AstraZeneca Rapid-dissolving Tablets Product Portfolio
- 4.4.5 AstraZeneca Recent Developments
- 4.5 GSK
- 4.5.1 GSK Company Information
- 4.5.2 GSK Business Overview
- 4.5.3 GSK Rapid-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GSK Rapid-dissolving Tablets Product Portfolio
- 4.5.5 GSK Recent Developments
- 4.6 Pfizer
- 4.6.1 Pfizer Company Information
- 4.6.2 Pfizer Business Overview
- 4.6.3 Pfizer Rapid-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Rapid-dissolving Tablets Product Portfolio
- 4.6.5 Pfizer Recent Developments
- 4.7 Eli Lilly and Company
- 4.7.1 Eli Lilly and Company Company Information
- 4.7.2 Eli Lilly and Company Business Overview
- 4.7.3 Eli Lilly and Company Rapid-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Eli Lilly and Company Rapid-dissolving Tablets Product Portfolio
- 4.7.5 Eli Lilly and Company Recent Developments
- 4.8 Mylan
- 4.8.1 Mylan Company Information
- 4.8.2 Mylan Business Overview
- 4.8.3 Mylan Rapid-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Mylan Rapid-dissolving Tablets Product Portfolio
- 4.8.5 Mylan Recent Developments
- 4.9 Merck
- 4.9.1 Merck Company Information
- 4.9.2 Merck Business Overview
- 4.9.3 Merck Rapid-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Merck Rapid-dissolving Tablets Product Portfolio
- 4.9.5 Merck Recent Developments
- 4.10 Johnson and Johnson
- 4.10.1 Johnson and Johnson Company Information
- 4.10.2 Johnson and Johnson Business Overview
- 4.10.3 Johnson and Johnson Rapid-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Johnson and Johnson Rapid-dissolving Tablets Product Portfolio
- 4.10.5 Johnson and Johnson Recent Developments
- 4.11 Teva
- 4.11.1 Teva Company Information
- 4.11.2 Teva Business Overview
- 4.11.3 Teva Rapid-dissolving Tablets Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Teva Rapid-dissolving Tablets Product Portfolio
- 4.11.5 Teva Recent Developments
5 Global Rapid-dissolving Tablets Market Scenario by Region
- 5.1 Global Rapid-dissolving Tablets Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Rapid-dissolving Tablets Sales by Region: 2021-2032
- 5.2.1 Global Rapid-dissolving Tablets Sales by Region: 2021-2026
- 5.2.2 Global Rapid-dissolving Tablets Sales by Region: 2027-2032
- 5.3 Global Rapid-dissolving Tablets Revenue by Region: 2021-2032
- 5.3.1 Global Rapid-dissolving Tablets Revenue by Region: 2021-2026
- 5.3.2 Global Rapid-dissolving Tablets Revenue by Region: 2027-2032
- 5.4 North America Rapid-dissolving Tablets Market Facts & Figures by Country
- 5.4.1 North America Rapid-dissolving Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Rapid-dissolving Tablets Sales by Country (2021-2032)
- 5.4.3 North America Rapid-dissolving Tablets Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Rapid-dissolving Tablets Market Facts & Figures by Country
- 5.5.1 Europe Rapid-dissolving Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Rapid-dissolving Tablets Sales by Country (2021-2032)
- 5.5.3 Europe Rapid-dissolving Tablets Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Rapid-dissolving Tablets Market Facts & Figures by Country
- 5.6.1 Asia Pacific Rapid-dissolving Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Rapid-dissolving Tablets Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Rapid-dissolving Tablets Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Rapid-dissolving Tablets Market Facts & Figures by Country
- 5.7.1 South America Rapid-dissolving Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Rapid-dissolving Tablets Sales by Country (2021-2032)
- 5.7.3 South America Rapid-dissolving Tablets Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Rapid-dissolving Tablets Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Rapid-dissolving Tablets Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Rapid-dissolving Tablets Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Rapid-dissolving Tablets Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Rapid-dissolving Tablets Sales by Type (2021-2032)
- 6.1.1 Global Rapid-dissolving Tablets Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Rapid-dissolving Tablets Sales Market Share by Type (2021-2032)
- 6.2 Global Rapid-dissolving Tablets Revenue by Type (2021-2032)
- 6.2.1 Global Rapid-dissolving Tablets Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Rapid-dissolving Tablets Revenue Market Share by Type (2021-2032)
- 6.3 Global Rapid-dissolving Tablets Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Rapid-dissolving Tablets Sales by Application (2021-2032)
- 7.1.1 Global Rapid-dissolving Tablets Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Rapid-dissolving Tablets Sales Market Share by Application (2021-2032)
- 7.2 Global Rapid-dissolving Tablets Revenue by Application (2021-2032)
- 7.2.1 Global Rapid-dissolving Tablets Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Rapid-dissolving Tablets Revenue Market Share by Application (2021-2032)
- 7.3 Global Rapid-dissolving Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Rapid-dissolving Tablets Value Chain Analysis
- 8.1.1 Rapid-dissolving Tablets Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Rapid-dissolving Tablets Production Mode & Process
- 8.2 Rapid-dissolving Tablets Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Rapid-dissolving Tablets Distributors
- 8.2.3 Rapid-dissolving Tablets Customers
9 Global Rapid-dissolving Tablets Analyzing Market Dynamics
- 9.1 Rapid-dissolving Tablets Industry Trends
- 9.2 Rapid-dissolving Tablets Industry Drivers
- 9.3 Rapid-dissolving Tablets Industry Opportunities and Challenges
- 9.4 Rapid-dissolving Tablets Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst